Abstract
The coronavirus disease 2019 (COVID-19) pandemic has placed laboratory medicine at the forefront of public health and clinical care. Larger use of social media and official communication platforms raised public awareness of laboratory science, driving demand for rapid, accurate diagnostic information and shifting expectations around access and interpretation of testing. Laboratory medicine, rooted in accuracy, precision, reproducibility and clinical relevance, has advanced from basic diagnostics to sophisticated molecular and data-driven platforms. Yet, literature and policy on coordinated international laboratory networks, especially for surveillance and emergency response, remain limited. This opinion paper introduces the concept of “global-of-care testing”, encompassing globally connected diagnostic infrastructures with regional adaptability, robust governance, and sustained investment in technology and workforce. Laboratory network design must account for geography and population density in allocating facilities. Integrated systems require automation capable of interfacing across multiple platforms (preanalytical processing, clinical chemistry, immunochemistry, hematology, coagulation, urinalysis and even molecular diagnostics and mass spectrometry) to optimize workflows, support real-time decision-making, facilitate remote collaboration and maintain rigorous quality assurance. A decentralized yet interconnected model allows peripheral laboratories to actively participate in clinical decision-making through shared protocols, telemedicine and integrated data, ultimately reducing turnaround times, improving responsiveness and enhancing patient-centred care. Embedding Value-Based Laboratory Medicine (VBLM) within this framework ensures that diagnostics are aligned with health outcomes in a multidisciplinary ecosystem organized around patient needs. The future of laboratory medicine will hence depend on evidence-based reforms that integrate technology, reorganize systems and reinforce governance for promoting quality, equitable access and sustainable precision healthcare.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: The authors wish to disclose that ChatGPT 3.5 was used for enhancing the clarity and coherence of the manuscript writing. The tool was only used for language refinement purposes, ensuring the text was clear and coherent without altering the scientific content or generating any new text. Figure 1 was created with the help of Chatbot.
-
Conflict of interest: The authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: All data are included in the article.
References
1. Lippi, G, Plebani, M. Clinical chemistry laboratory medicine in the post-acute COVID-19 era. Clin Chem Lab Med 2024;62:1651–2. https://doi.org/10.1515/cclm-2024-0756.Suche in Google Scholar PubMed
2. Elhakim, M, Elkholy, A, Stephen, M, Brennan, RJ, Zouiten, A. Two rounds of the pandemic fund at the WHO Eastern mediterranean region: progress, lessons learned, challenges, and way forward. Glob Health Action 2025;18:2475596. https://doi.org/10.1080/16549716.2025.2475596.Suche in Google Scholar PubMed PubMed Central
3. Parums, DV. The 2025 world health assembly pandemic agreement and the 2024 amendments to the international health regulations combine for pandemic preparedness and response. Med Sci Monit 2025;31:e950411. https://doi.org/10.12659/msm.950411.Suche in Google Scholar PubMed PubMed Central
4. Ministero della Salute. Decreto 23 maggio 2022 n. 77. Regolamento recante la definizione di modelli e standard per lo sviluppo dell’assistenza territoriale nel Servizio sanitario nazionale. Gazzetta Ufficiale – Serie Generale; 2022. n. 144 del 22 giugno 2022 https://www.gazzettaufficiale.it/eli/id/2022/06/22/22G00085/sg [Accessed 21 Feb 2024].Suche in Google Scholar
5. Vinceti, SR. Reorganizing Italy’s territorial healthcare: the ministerial decree no. 77/2022 and its comparative significance. Ann Ig 2023;35:367–71. https://doi.org/10.7416/ai.2023.2556. Epub 2023 Feb 3. PMID: 36753333.Suche in Google Scholar PubMed
6. Mauro, M, Giancotti, M. The 2022 primary care reform in Italy: improving continuity and reducing regional disparities? Health Policy 2023;135:104862. https://doi.org/10.1016/j.healthpol.2023.104862.Suche in Google Scholar PubMed
7. Gabrielli, E, Schenone, I, Cornio, AR, Cerri, A, DI Pumpo, M, Troia, A, et al.. Characteristics of the health districts in Italy and their implication in primary health care policies: an analysis of socio-demographic trends. J Prev Med Hyg 2024;65:E50–8. https://doi.org/10.15167/2421-4248/jpmh2024.65.1.3118.Suche in Google Scholar PubMed PubMed Central
8. Ricciardi, W, Tarricone, R. The evolution of the Italian national health service. Lancet 2021;398:2193–206. https://doi.org/10.1016/s0140-6736-21-01733-5.Suche in Google Scholar
9. Ognibene, A, Conti, AA, Lorubbio, M, Conti, A. STORE (sample tracking: organization, refrigeration and expansion): a project in a clinical laboratory perspective. Clin Chem Lab Med 2016;54:e109–11. https://doi.org/10.1515/cclm-2015-1032.Suche in Google Scholar PubMed
10. Biever, C. ChatGPT broke the turing test – the race is on for new ways to assess AI. Nature 2023;619:686–9. https://doi.org/10.1038/d41586-023-02361-7.Suche in Google Scholar PubMed
11. Plebani, M, Cadamuro, J, Vermeersch, P, Jovičić, S, Ozben, T, Trenti, T, et al.. A vision to the future: value-based laboratory medicine. Clin Chem Lab Med 2024;62:2373–87. https://doi.org/10.1515/cclm-2024-1022.Suche in Google Scholar PubMed
12. Cadamuro, J, Carobene, A, Cabitza, F, Debeljak, Z, De Bruyne, S, van Doorn, W, et al.. A comprehensive survey of artificial intelligence adoption in European laboratory medicine: current utilization and prospects. Clin Chem Lab Med 2024;63:692–703. https://doi.org/10.1515/cclm-2024-1016.Suche in Google Scholar PubMed
13. Çubukçu, HC, Boursier, G, Linko, S, Bernabeu-Andreu, FA, Meško Brguljan, P, Tosheska-Trajkovska, K, et al.. Regulating the future of laboratory medicine: european regulatory landscape of AI-driven medical device software in laboratory medicine. Clin Chem Lab Med 2025;28. https://doi.org/10.1515/cclm-2025-0482. Epub ahead of print.Suche in Google Scholar PubMed
14. Lippi, G, Akhvlediani, S, Cadamuro, J, Danese, E, García de Guadiana Romualdo, L, Delacour, H, et al.. EFLM task force preparation of labs for emergencies (TF-PLE) recommendations for reinforcing cyber-security and managing cyber-attacks in medical laboratories. Clin Chem Lab Med 2024;63:27–34. https://doi.org/10.1515/cclm-2024-0803.Suche in Google Scholar PubMed
15. Lippi, G, Cadamuro, J, Danese, E, Favaloro, EJ, Favresse, J, Henry, BM, et al.. EFLM task force preparation of labs for emergencies (TF-PLE) survey on cybersecurity. Clin Chem Lab Med 2024;63:e1–2. https://doi.org/10.1515/cclm-2024-0727.Suche in Google Scholar PubMed
16. Lippi, G, Plebani, M. Specialization in laboratory medicine [non è (Più) un paese per laboratoristi]. Biochim Clin 2025;49:53–5. https://doi.org/10.23736/s0393-0564.24.00012-0.Suche in Google Scholar
17. Plebani, M. Value-based laboratory medicine: the time is now. Clin Chem Lab Med 2023;62:579–80. https://doi.org/10.1515/cclm-2023-1095.Suche in Google Scholar PubMed
18. Plebani, M. A value-based score for clinical laboratories: promoting the work of the new EFLM committee. Clin Chem Lab Med 2025;63:1481–5. https://doi.org/10.1515/cclm-2025-0490.Suche in Google Scholar PubMed
19. Mattiuzzi, C, Lippi, G. COVID-19: lessons from the past to inform the future of healthcare. COVID 2025;5:4. https://doi.org/10.3390/covid5010004.Suche in Google Scholar
20. Plebani, M, Nichols, JH, Luppa, PB, Greene, D, Sciacovelli, L, Shaw, J, et al.. Point-of-care testing: state-of-the art and perspectives. Clin Chem Lab Med 2024;63:35–51. https://doi.org/10.1515/cclm-2024-0675.Suche in Google Scholar PubMed
21. Plebani, M, Coskun, A. Promoting value-based laboratory medicine: moving towards an innovative model of clinical laboratory. Clin Chim Acta 2025;572:120269. https://doi.org/10.1016/j.cca.2025.120269.Suche in Google Scholar PubMed
22. Rubinstein, ML, Plebani, M. Advancing diagnostic stewardship through claims-based utilization analysis: toward a system-wide vision of diagnostic excellence. Clin Chem Lab Med 2025;8. https://doi.org/10.1515/cclm-2025-0861. Epub ahead of print.Suche in Google Scholar PubMed
23. Lippi, G, Plebani, M. Cost, profitability and value of laboratory diagnostics: in god we trust, all others bring data. J Lab Med 2019;43:1–3. https://doi.org/10.1515/labmed-2018-0321.Suche in Google Scholar
© 2025 Walter de Gruyter GmbH, Berlin/Boston